Point72 Hong Kong LTD Ideaya Biosciences, Inc. Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.28 - $13.88 $27,953 - $46,858	-3,376 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$11.18 - $24.02 $29,604 - $63,604	2,648 Added 363.74%	3,376 $38,000
Q4 2021 Feb 14, 2022	BUY	$20.95 - $26.88 $15,251 - $19,568	728 New	728 $17,000
Q2 2021 Aug 16, 2021	SELL	$17.76 - $24.83 $9,554 - $13,358	-538 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$13.48 - $23.77 $3,423 - $6,037	254 Added 89.44%	538 $13,000
Q4 2020 Feb 16, 2021	BUY	$12.17 - $17.52 $3,456 - $4,975	284 New	284 $4,000
Q3 2020 Nov 16, 2020	SELL	$11.22 - $14.46 $1,817 - $2,342	-162 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.59 - $18.57 $118 - $612	-33 Reduced 16.92%	162 $2,000
Q3 2019 Nov 14, 2019	SELL	$6.06 - $10.91 $6,350 - $11,433	-1,048 Reduced 84.31%	195 $2,000
Q2 2019 Aug 14, 2019	BUY	$9.58 - $11.95 $11,907 - $14,853	1,243 New	1,243 $12,000

206

73.6M

21.5K

20.3K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.48B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.